drugset / Trial / NCT07000695

Managed Access Programs for TQJ230, Pelacarsen

NCT07000695 ↗

Expanded access Available Novartis Pharmaceuticals

Summary

The purpose of this registration is to list Managed Access Programs (MAPs) related to TQJ230, pelacarsen

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Background Pelacarsen Antisense oligonucleotide — —